CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 40 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $72,000 | +35.8% | 14,949 | -24.3% | 0.01% | -44.4% |
| Q2 2021 | $53,000 | -59.8% | 19,737 | -53.9% | 0.02% | -57.1% |
| Q1 2021 | $132,000 | +140.0% | 42,857 | +177.1% | 0.04% | +162.5% |
| Q4 2020 | $55,000 | +22.2% | 15,467 | +37.5% | 0.02% | +14.3% |
| Q3 2020 | $45,000 | +25.0% | 11,247 | -33.6% | 0.01% | -6.7% |
| Q1 2020 | $36,000 | – | 16,947 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $8,746,000 | 1.82% |
| Telemetry Investments, L.L.C. | 263,975 | $705,000 | 0.97% |
| CHI Advisors LLC | 719,132 | $1,920,000 | 0.45% |
| BVF INC/IL | 3,678,626 | $9,822,000 | 0.37% |
| EcoR1 Capital, LLC | 3,579,377 | $9,557,000 | 0.36% |
| Orbimed Advisors | 8,053,298 | $21,502,000 | 0.22% |
| Stonepine Capital Management, LLC | 46,886 | $125,000 | 0.06% |
| Ikarian Capital, LLC | 100,000 | $267,000 | 0.02% |
| ALGERT GLOBAL LLC | 19,737 | $53,000 | 0.02% |
| Windsor Creek Advisors, LLC | 14,786 | $39,000 | 0.01% |